Multinational Australian labs giant Sonic is buying Diagnosticum, a medium-sized German labs chain which operates 15 laboratories and employs 25 pathologists, for €190m.
Two of Australia’s largest diagnostic groups by revenue may about to merge: pathology chain Australian Clinical Labs (ACL) has made a A$1.52bn (US$1.02bn) offer for Healius, a larger rival which has diagnostic imaging capacity as well.
London-based PE group Apposite Capital is among the most active investors in health care in Europe. HBI chats with managing partner Sam Gray about the state of the market and pricing, how he sees that changing, and the investment opportunities piquing his interest at present.
Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
London headquartered global PE firm Cinven has submitted a non-binding offer to fully take over Europe's largest lab group Synlab, the company confirmed today, following speculation it was looking to take the group private.
Last month, thought leaders from private healthcare systems across the globe gathered in Cape Town, South Africa, to network, share their findings, and consider how emerging markets can become more resilient. HBI was there, and these are our key themes and takeaways.
Sources at the Arab Health exhibition confirm that the ambitious Saudi 2030 project which will see the country transfer most health care service delivery to the for-profit sector is still on. What are the implications of this?
Big Saudi lab group Al Borg plans to use franchising to grow rapidly with a consumer-led offer which includes imaging and primary care. It is also constructing two enormous reference labs in Riyad and Jeddah with the aim of seizing a market where Saudi spends billions. The group is also still eyeing a stock market listing.
A group of journalists from German broadcasting companies Westdeutscher Rundfunk (WDR) and Norddeutscher Rundfunk (NDR) and German daily newspaper Süddeutsche Zeitung (SZ) has accused Germany’s private labs groups of lobbying the government in order to protect their Covid testing profits.
The unions representing French labs groups called an end to their strike on Tuesday, January 10, after reaching an agreement with the government on tariff cuts for 2023. The agreement specifies that up to €250m of labs’ funding can be cut in 2023, but that no further cuts will be made during the year. While this deal ends the immediate problem, HBI hears it has only delayed further conflict.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
